Top Strike Announces Majority Ownership of Galenas New Jersey LLC
CALGARY, Alberta, Jan. 14, 2020 (GLOBE NEWSWIRE) — Top Strike Resources Corp. d.b.a. “Vencanna Ventures” (the “Corporation” or “Vencanna“) (CSE:VENI; [...]
Westcot Ventures Corp. Announces Name Change to “WPD Pharmaceuticals Inc.”
VANCOUVER, British Columbia, Jan. 14, 2020 (GLOBE NEWSWIRE) — Westcot Ventures Corp (CSE: WBIO) (the “Company”), a clinical stage pharmaceutical […]
Huazhu Group Limited Announces Preliminary Results for Hotel Operations in the Fourth Quarter and the Full Year of 2019
SHANGHAI, China, Jan. 14, 2020 (GLOBE NEWSWIRE) — Huazhu Group Limited (NASDAQ: HTHT) (“Huazhu” or “our”), a leading and fast-growing […]
Teledyne e2v expands its Emerald image sensor family with new 36 Mpixel high-speed chip
GRENOBLE, France, Jan. 14, 2020 (GLOBE NEWSWIRE) — Teledyne e2v, a Teledyne Technologies [NYSE: TDY] company and global innovator of […]
Teledyne e2v, 신형 36 메가픽셀 고속 칩으로 Emerald 이미지 센서 제품군 확대
프랑스, 그르노블, Jan. 14, 2020 (GLOBE NEWSWIRE) — Teledyne Technologies[NYSE: TDY]의 계열사이자 이미징 솔루션 분야의 세계적인 선도 혁신 기업인 Teledyne […]
Teledyne e2vは、新しく36メガピクセル高速チップを搭載した、Emeraldイメージセンサーファミリーを拡張
GRENOBLE, France, Jan. 14, 2020 (GLOBE NEWSWIRE) — Teledyne Technologies（NYSE: TDY）の傘下でイメージングソリューションの世界的なイノベーターであるTeledyne e2vは、新製品のEmerald [...]
Teledyne e2v 使用新的 36 百萬像素高速晶片擴增其 Emerald 影像感測器系列
法國格勒諾布爾, Jan. 14, 2020 (GLOBE NEWSWIRE) — Teledyne e2v 是 Teledyne Technologies [NYSE:TDY] 公司暨全球影像處理解決方案創新者，公佈其新的 Emerald 36M，亦即 37.7 百萬像素影像感測器，專為需要高解析度和高速的工業及戶外困難應用量身打造。Emerald 36M 以獨特方式結合了 [...]
Astellas and Adaptimmune Enter into Agreement to Co-Develop and Co-Commercialize Stem-Cell Derived Allogeneic CAR-T and TCR T-Cell Therapies
– Agreement covers the co-development and co-commercialization of up to three T-cell therapies –– Agreement leverages Astellas’ Universal Donor Cell […]
NXP Accelerates UWB-based Mobile Payment Innovation with NTT DOCOMO and Sony
TOKYO, Jan. 14, 2020 (GLOBE NEWSWIRE) — NXP Semiconductors N.V. (NASDAQ: NXPI) today announced its Ultra-Wideband (UWB) solution will be […]
Biofrontera announces 1-year follow-up results for its phase III study of photodynamic therapy for actinic keratosis on the extremities and trunk/neck
Leverkusen, Germany, Jan. 14, 2020 (GLOBE NEWSWIRE) — Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (the “Company”), an international […]
